338 related articles for article (PubMed ID: 35044388)
1. An active-passive strategy for enhanced synergistic photothermal-ferroptosis therapy in the NIR-I/II biowindows.
Wu F; Chen H; Liu R; Suo Y; Li Q; Zhang Y; Liu H; Cheng Z; Chang Y
Biomater Sci; 2022 Feb; 10(4):1104-1112. PubMed ID: 35044388
[TBL] [Abstract][Full Text] [Related]
2. Multivalent Polypeptide and Tannic Acid Cooperatively Iron-Coordinated Nanohybrids for Synergistic Cancer Photothermal Ferroptosis Therapy.
He M; Du C; Xia J; Zhang ZG; Dong CM
Biomacromolecules; 2022 Jun; 23(6):2655-2666. PubMed ID: 35583462
[TBL] [Abstract][Full Text] [Related]
3. Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal/chemodynamic combined ferroptosis therapy treating gastric cancer.
Chen Z; Li Z; Li C; Huang H; Ren Y; Li Z; Hu Y; Guo W
Drug Deliv; 2022 Dec; 29(1):1201-1211. PubMed ID: 35403518
[TBL] [Abstract][Full Text] [Related]
4. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
6. Phototheranostic nanoparticles with aggregation-induced emission as a four-modal imaging platform for image-guided photothermal therapy and ferroptosis of tumor cells.
Wang Z; Wang Y; Gao H; Tang C; Feng Z; Lin L; Che S; Luo C; Ding D; Zheng D; Yu Z; Peng Z
Biomaterials; 2022 Oct; 289():121779. PubMed ID: 36099712
[TBL] [Abstract][Full Text] [Related]
7. Ultrasmall Cu
Hu R; Fang Y; Huo M; Yao H; Wang C; Chen Y; Wu R
Biomaterials; 2019 Jun; 206():101-114. PubMed ID: 30927714
[TBL] [Abstract][Full Text] [Related]
8. Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect.
Dong Y; Dong S; Wang Z; Feng L; Sun Q; Chen G; He F; Liu S; Li W; Yang P
ACS Appl Mater Interfaces; 2020 Nov; 12(47):52479-52491. PubMed ID: 33196186
[TBL] [Abstract][Full Text] [Related]
9. Copperphosphotungstate Doped Polyanilines Nanorods for GSH-Depletion Enhanced Chemodynamic/NIR-II Photothermal Synergistic Therapy.
Ye S; Xiao H; Chen J; Zhang D; Qi L; Peng T; Gao Y; Zhang Q; Qu J; Wang L; Liu R
Int J Nanomedicine; 2023; 18():1245-1257. PubMed ID: 36937549
[TBL] [Abstract][Full Text] [Related]
10. Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms.
Wang C; Dai C; Hu Z; Li H; Yu L; Lin H; Bai J; Chen Y
Nanoscale Horiz; 2019 Mar; 4(2):415-425. PubMed ID: 32254094
[TBL] [Abstract][Full Text] [Related]
11. Near Infrared-Triggered Theranostic Nanoplatform with Controlled Release of HSP90 Inhibitor for Synergistic Mild Photothermal and Enhanced Nanocatalytic Therapy with Hypoxia Relief.
Tian B; Wang C; Du Y; Dong S; Feng L; Liu B; Liu S; Ding H; Gai S; He F; Yang P
Small; 2022 Jul; 18(28):e2200786. PubMed ID: 35661402
[TBL] [Abstract][Full Text] [Related]
12. Mild photothermal/radiation therapy potentiates ferroptosis effect for ablation of breast cancer via MRI/PA imaging guided all-in-one strategy.
Zhang Z; Lo H; Zhao X; Li W; Wu K; Zeng F; Li S; Sun H
J Nanobiotechnology; 2023 May; 21(1):150. PubMed ID: 37158923
[TBL] [Abstract][Full Text] [Related]
13. Nanocatalysts-Augmented and Photothermal-Enhanced Tumor-Specific Sequential Nanocatalytic Therapy in Both NIR-I and NIR-II Biowindows.
Feng W; Han X; Wang R; Gao X; Hu P; Yue W; Chen Y; Shi J
Adv Mater; 2019 Feb; 31(5):e1805919. PubMed ID: 30536723
[TBL] [Abstract][Full Text] [Related]
14. Au-Fe
Wei R; Fu G; Li Z; Liu Y; Qi L; Liu K; Zhao Z; Xue M
J Colloid Interface Sci; 2024 Jun; 663():644-655. PubMed ID: 38430834
[TBL] [Abstract][Full Text] [Related]
15. Complementing Cancer Photodynamic Therapy with Ferroptosis through Iron Oxide Loaded Porphyrin-Grafted Lipid Nanoparticles.
Liang X; Chen M; Bhattarai P; Hameed S; Tang Y; Dai Z
ACS Nano; 2021 Dec; 15(12):20164-20180. PubMed ID: 34898184
[TBL] [Abstract][Full Text] [Related]
16. Ultrasmall Zwitterionic Polypeptide-Coordinated Nanohybrids for Highly Efficient Cancer Photothermal Ferrotherapy.
Du C; Zhou L; Qian J; He M; Zhang ZG; Feng C; Zhang Y; Zhang R; Dong CM
ACS Appl Mater Interfaces; 2021 Sep; 13(37):44002-44012. PubMed ID: 34494817
[TBL] [Abstract][Full Text] [Related]
17. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
18. Ellagic acid-Fe@BSA nanoparticles for endogenous H
Tian Q; An L; Tian Q; Lin J; Yang S
Theranostics; 2020; 10(9):4101-4115. PubMed ID: 32226542
[No Abstract] [Full Text] [Related]
19. Multifunctional NIR-responsive poly(vinylpyrrolidone)-Cu-Sb-S nanotheranostic agent for photoacoustic imaging and photothermal/photodynamic therapy.
Hou M; Yan C; Chen Z; Zhao Q; Yuan M; Xu Y; Zhao B
Acta Biomater; 2018 Jul; 74():334-343. PubMed ID: 29753138
[TBL] [Abstract][Full Text] [Related]
20. Coordinating the Mechanisms of Action of Ferroptosis and the Photothermal Effect for Cancer Theranostics.
Zeng F; Tang L; Zhang Q; Shi C; Huang Z; Nijiati S; Chen X; Zhou Z
Angew Chem Int Ed Engl; 2022 Mar; 61(13):e202112925. PubMed ID: 34932846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
